
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
16/7/2013
0:00
5:10
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
Otros episodios de "The Biopharma Pod"



No te pierdas ningún episodio de “The Biopharma Pod”. Síguelo en la aplicación gratuita de GetPodcast.








